2025-09-30T14:49:01-04:00 2024-12-31 WITHUMSMITHBROWN PC 1835 MARKET STREET SUITE 1710 PHILADELPHIA PA 191032945 990 2024-01-01 236251648 American Association for Cancer Research Inc % MICHAEL STEWART AMER 2154409300 615 Chestnut Street 17th FL Philadelphia PA 19106 MICHAEL STEWART Senior VP, CFO 2154409300 2025-08-15 true true THOMAS PARISI P00013287 2155462140 2024 2025-03-06 01:10:19Z MICHAEL STEWART 615 Chestnut Street 17th FL Philadelphia PA 19106 196793435 false X www.aacr.org X 1907 NY PREVENT AND CURE CANCER THROUGH RESEARCH, EDUCATION, COMMUNICATION AND COLLABORATION. 24 24 301 5500 507511 179878 16080259 48246384 58133068 67669562 -761850 20614173 864892 898245 74316369 137428364 13561946 11210125 0 0 28837718 32905715 0 0 1204000 37802393 43916619 80202057 88032459 -5885688 49395905 241949585 291810436 71485232 71615546 170464353 220194890 X THE MISSION OF THE AACR IS TO PREVENT AND CURE CANCER THROUGH RESEARCH, EDUCATION, COMMUNICATION, AND COLLABORATION. THROUGH ITS PROGRAMS AND SERVICES, THE AACR FOSTERS RESEARCH IN CANCER AND RELATED BIOMEDICAL SCIENCE; ACCELERATES THE DISSEMINATION OF NEW RESEARCH FINDINGS AMONG SCIENTISTS AND OTHERS DEDICATED TO THE CONQUEST OF CANCER; PROMOTES SCIENCE EDUCATION AND TRAINING; AND ADVANCES THE UNDERSTANDING OF CANCER ETIOLOGY, PREVENTION, DIAGNOSIS AND TREATMENT THROUGHOUT THE WORLD. false false 14700817 10633753 RESEARCH GRANTS, SCIENTIFIC AWARDS, FELLOWSHIPS AND CAREER DEVELOPMENT AWARDS. 24519657 378200 33662478 ANNUAL MEETING AND SPECIAL CONFERENCES ATTENDED BY MEMBERS AND NON-MEMBERS FOR THE PRESENTATION OF SCIENTIFIC RESEARCH. ALSO INCLUDES EDUCATIONAL WORKSHOPS FOR TRAINING YOUNG INVESTIGATORS. 13312612 18781283 PUBLICATIONS - PRODUCTION & DISTRIBUTION OF THE JOURNALS: "CANCER RESEARCH", "MOLECULAR CANCER RESEARCH", "CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION", "CLINICAL CANCER RESEARCH", "MOLECULAR CANCER THERAPEUTICS", "CANCER PREVENTION RESEARCH", "CANCER DISCOVERY", "CANCER IMMUNOLOGY RESEARCH", "BLOOD CANCER DISCOVERY", AND "CANCER RESEARCH COMMUNICATIONS". 2450805 0 0 SCIENCE POLICY AND GOVERNMENT AFFAIRS 5816694 0 0 COMMUNICATIONS 2963052 198172 579758 SPECIAL CONSTITUENCIES 10712022 0 10388651 SCIENTIFIC PROJECTS AND PROGRAMS 522201 0 0 SURVIVOR PROGRAM 0 0 4257392 MEMBERSHIP 1381693 0 0 CANCER TODAY MAGAZINE 23846467 198172 15225801 76379553 true true false true false false false false false true true true false true true true false true false false true false true false false false false false true true false false false false false false false false false false false false false true true false false false true 472 0 true 301 true true true true CA false false false false false false false false true false X 24 24 false false false false true true true true true false false true true true true true true true true false AL AK AR CA CO CT DC FL GA HI IL KS KY LA ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X MICHAEL STEWART 2154409300 615 CHESTNUT STREET 17TH FLOOR PHILADELPHIA PA 19106 X DR MARGARET FOTI CHIEF EXECUTIVE OFFICER 35.0 5.0 X 1809255 201028 64914 MICHAEL STEWART SR. VICE PRESIDENT, CFO 35.0 5.0 X 430500 22500 64403 JON G RETZLAFF VP. Science Policy & Gov. Affa 40.0 0.0 X 403520 0 55903 YIXIAN ZHANG VP, RESEARCH AND GRANTS 40.0 0.0 X 312000 0 60956 PAUL J DRISCOLL CHIEF MARKETING OFFICER AND VP 40.0 0.0 X 308700 0 58972 CHRISTINE B BATTLE VP. SCIENTIFIC PUBLICATIONS 40.0 0.0 X 326000 0 39841 RICHARD G BUCK CHIEF COMMUNICATIONS OFFICER 40.0 0.0 X 304350 0 52883 JOSEPH S PONTOSKI VP. FINANCE AND BUSINESS ADMIN 40.0 0.0 X 300000 0 50363 MARY BALLINGER VP, MEETINGS AND EXHIBITS 40.0 0.0 X 270750 0 50195 DR PHILIP GREENBERG PRESIDENT (JAN-MAR) 5.0 2.0 X X 0 0 0 DR PATRICIA LORUSSO PRESIDENT (APR-DEC) 5.0 0.0 X X 0 0 0 DR PATRICIA LORUSSO PRESIDENT-ELECT (JAN-MAR) 5.0 2.0 X X 0 0 0 DR LILLIAN SUI PRESIDENT-ELECT (APR-DEC) 5.0 0.0 X X 0 0 0 DR LISA COUSSENS PAST PRESIDENT (JAN-MAR) 5.0 0.0 X X 0 0 0 DR PHILIP GREENBERG PAST PRESIDENT (APR-DEC) 5.0 2.0 X X 0 0 0 DR WILLIAM N HAIT TREASURER 5.0 0.0 X X 0 0 0 Dr JOHN CARETHERS DIRECTOR 2.0 0.0 X 0 0 0 DR CHRISTINE LOVLY DIRECTOR 2.0 0.0 X 0 0 0 DR ELIZABETH PLATZ DIRECTOR 2.0 0.0 X 0 0 0 DR ALICE SHAW DIRECTOR 2.0 0.0 X 0 0 0 DR JEDD WOLCHOK DIRECTOR 2.0 0.0 X 0 0 0 DR CHRISTINA CURTIS DIRECTOR 2.0 0.0 X 0 0 0 DR WILLIAM PAO DIRECTOR 2.0 0.0 X 0 0 0 DR KIMBERLY STEGMAIER DIRECTOR 2.0 0.0 X 0 0 0 DR ROBERT VONDERHEIDE DIRECTOR 2.0 0.0 X 0 0 0 DR JOHN CARPTEN DIRECTOR 2.0 0.0 X 0 0 0 DR MANUEL HIDALGO DIRECTOR 2.0 0.0 X 0 0 0 DR ELECTRA PASKETT DIRECTOR 2.0 0.0 X 0 0 0 DR KATERINA POLITI DIRECTOR 2.0 0.0 X 0 0 0 DR JEAN-CHARLES SORIA DIRECTOR 2.0 0.0 X 0 0 0 DR CATHERINE WU DIRECTOR 2.0 0.0 X 0 0 0 DR NINA BHARDWAJ DIRECTOR 2.0 0.0 X 0 0 0 DR LUIS DIAZ DIRECTOR 2.0 0.0 X 0 0 0 DR SUSAN GALBRAITH DIRECTOR 2.0 0.0 X 0 0 0 DR THOMAS LYNCH DIRECTOR 2.0 0.0 X 0 0 0 DR LISA NEWMAN DIRECTOR 2.0 0.0 X 0 0 0 4465075 223528 498430 76 false true false FREEMAN po box 650036 dallas TX 75265 AUDIO VISUAL SERVICE 4865124 REACTION AUDIO VISUAL 30400 Esperanza Rancho Santa Margarita CA 92688 AUDIO VISUAL SERVICE 1705429 TRANSPORTATION MANAGEMENT 17810 Meeting House Road Suite 200 Sandy Spring MD 20860 Transportation 1086713 DUANE MORRIS LLP 30 SOUTH 17TH ST PHILADELPHIA PA 191034196 LEGAL SERVICES 770639 ATTAIN CONSULTING GROUP 1600 TYSONS BOULEVARD MCLEAN VA 22102 CONSULTING 769558 63 47916782 329602 0 48246384 MEETING AND EDUCATION 541800 33662478 26094728 241095 7326655 PUBLICATIONS 541800 18781283 18564474 216809 SCIENTIFIC INITIATIVES 541800 10388651 10388651 MEMBERSHIP DUES 541800 4257392 4257392 All Other Programs 900099 579758 579758 67669562 3513317 49607 3463710 0 898245 898245 0 0 0 76465927 59365071 17100856 17100856 17100856 0 0 0 0 0 0 0 0 0 0 137428364 59885003 507511 28789466 0 9219125 9219125 1991000 1991000 0 3159511 2591723 567788 0 22928072 18807727 4120345 1712201 1404506 307695 3223436 2644161 579275 1882495 1544197 338298 0 991906 991906 27000 27000 512993 512993 0 1062096 1062096 8657635 7617824 1039811 2875327 2427923 447404 2946703 2678149 268554 2618816 2223132 395684 0 2372927 2198226 174701 3147594 3029782 117812 0 7307409 6930664 376745 0 1204000 1204000 99381 32344 67037 285251 272981 12270 Audio Visual Services 5809009 5664058 144951 CREDIT CARD FEES 1212165 1105452 106713 HONORARIA 1124814 1124814 Commercial Exhibits 748741 748741 912852 591125 321727 88032459 76379553 10448906 1204000 X 12659033 34456735 10534806 101268269 22506959 22436855 2459930 3218677 0 0 0 0 0 0 0 0 4512664 3164476 3147895 3082629 154051 65266 64058890 26035011 113716156 79799688 0 0 0 0 11347096 21365459 241949585 291810436 10140532 11636511 20502827 15033325 28940684 23272063 0 0 0 0 0 0 0 0 0 0 11901189 21673647 71485232 71615546 X 156067190 207958501 14397163 12236389 170464353 220194890 241949585 291810436 X 49395905 1738219 -1403587 X false true X true false X 48746614 44875975 26628085 16080259 48246384 184577317 53422477 48713405 44646425 49866024 59885003 256533334 334900 3729901 6046517 7803380 7326655 25241353 0 0 102503991 97319281 77321027 73749663 115458042 466352004 48631114 39834626 25847121 15552359 47916782 177782002 0 48631114 39834626 25847121 15552359 47916782 177782002 288570002 2188901 2160011 2770246 3659651 4411562 15190371 0 109445 117475 98312 102915 428147 2188901 2269456 2887721 3757963 4514477 15618518 0 0 104692892 99588737 80208748 77507626 119972519 481970522 0.59873 0.57010 0.03241 0.02930 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 205197 307796 512993 87519466 88032459 1000000 250000 1000000 1000000 1000000 1000000 4000000 6000000 232513 314831 404254 512993 1464591 250000 250000 250000 250000 1000000 1500000 93005 125932 161702 205197 585836 5836982 8000 594969 173268 6266683 5233272 8000 890013 294303 5836982 6629161 8000 -1209194 194695 5233272 6535395 9500 413441 329175 6629161 5563755 144455 1007185 180000 6535395 0.49240 0.50760 0.00000 false false 877844 877844 0 2270051 2204785 65266 65266 LIMITED PARTNERSHIPS 79799688 F 79799688 INVESTMENT IN SUBSIDIARY - FDN 4808026 OPERATING LEASE RIGHT-OF-USE 16557433 21365459 0 PAYABLE TO AFFILIATE 4716167 OPERATING LEASE LIABILITY 16957480 21673647 X 141751478 1738219 52941041 54679260 87072218 1062096 49294050 50356146 137428364 92048849 54372536 54372536 37676313 1062096 49294050 50356146 88032459 PART V, LINE 4: THE INCOME FROM THE FUNDS IS AVAILABLE TO SUPPORT THE PROGRAMS, SERVICES MISSION OF THE ACCR. PART X, LINE 2: The AACR is exempt from federal income tax under Section 501(c)(3) of the Internal Revenue Code. However, income from certain activities not directly related to the Organizations' tax-exempt purpose is subject to taxation as unrelated business income. In addition, the Organization qualifies for the charitable contribution deduction under Section 170(b)(1)(A) and the AACR has been classified as an organization other than a private foundation under Section 509(a)(2). AACR International - Canada was established in 2014 as a Canadian not for profit corporation and received its charity status in 2015. It is a wholly owned subsidiary of the AACR. GAAP requires entities to evaluate, measure, recognize and disclose any uncertain tax positions. GAAP prescribes a minimum threshold that a tax position is required to meet in order to be recognized in the financial statements. The AACR believes that they had no uncertain tax positions as defined in GAAP. PART XI, LINE 2D - OTHER ADJUSTMENTS REVENUE OF AFFILIATES - $52,941,041. PART XI, LINE 4B - OTHER ADJUSTMENTS INTERCOMPANY REVENUE - $49,294,050. PART XII, LINE 2D - OTHER ADJUSTMENTS EXPENSES OF AFFILIATES - $54,372,536 PART XII, LINE 4B, OTHER ADJUSTMENTS INTERCOMPANY EXPENSES - $49,294,050. true Europe (Including Iceland and Greenland) Grantmaking GRANT MAKING 1231000 North America Grantmaking GRANT MAKING 300000 Sub-Saharan Africa Grantmaking GRANT MAKING 220000 South America Grantmaking GRANT MAKING 165000 East Asia and the Pacific Grantmaking GRANT MAKING 75000 Central America and the Caribbean Investments 13062000 Europe (Including Iceland and Greenland) Investments 12609000 27662000 27662000 CAREER DEVELOPMENT AWARDS Europe (Including Iceland and Greenland) 3 806000 CHECK CAREER DEVELOPMENT AWARDS East Asia and the Pacific 1 75000 CHECK CAREER DEVELOPMENT AWARDS Sub-Saharan Africa 4 220000 CHECK CAREER DEVELOPMENT AWARDS South America 3 165000 CHECK CAREER DEVELOPMENT AWARDS North America 1 300000 CHECK INDEPENDENT RESEARCH GRANT Europe (Including Iceland and Greenland) 2 400000 CHECK SCIENTIFIC AWARD Europe (Including Iceland and Greenland) 2 25000 CHECK false false false false true false PART I, LINE 2: ALL GRANTEES ARE REQUIRED TO PROVIDE YEARLY PROGRESS REPORTS. ALL BUDGET ITEMS MUST BE JUSTIFIED IN CONNECTION WITH THE PROGRAM GUIDELINES; ANY DISCREPANCY OR UNEXPECTED FUNDS MUST BE RETURNED TO THE GRANTOR. PART I, LINE 3: THE ORGANIZATION USES THE ACCRUAL METHOD TO ACCOUNT FOR EXPENDITURES. true RESEARCH GRANTS 22 3993753 CAREER DEVELOPMENT AWARDS 11 2849000 INDEPENDENT RESEARCH GRANTS 8 1575000 SCIENTIFIC AWARDS 19 225000 TRAVEL AWARDS 256 576372 Part I Description of Procedure for Monitoring Use of Funds: All grantees are required to provide yearly progress reports. All budget items must be justified in connection with the program guidelines; any discrepancy or unexpected funds must be returned to the grantor. X true true X X X X false false false false false false false false false DR MARGARET FOTI CHIEF EXECUTIVE OFFICER 1170000 130000 405000 45000 234255 26028 24840 2760 33583 3731 1867678 207519 0 0 MICHAEL STEWART SR. VICE PRESIDENT, CFO 427500 22500 3000 0 0 0 34200 1800 26964 1439 491664 25739 0 0 JON G RETZLAFF VP. Science Policy & Gov. Affa 403520 0 0 0 0 0 32260 0 23643 0 459423 0 0 0 YIXIAN ZHANG VP, RESEARCH AND GRANTS 312000 0 0 0 0 0 24960 0 35996 0 372956 0 0 0 PAUL J DRISCOLL CHIEF MARKETING OFFICER AND VP 308700 0 0 0 0 0 24696 0 34276 0 367672 0 0 0 CHRISTINE B BATTLE VP. SCIENTIFIC PUBLICATIONS 326000 0 0 0 0 0 26080 0 13761 0 365841 0 0 0 RICHARD G BUCK CHIEF COMMUNICATIONS OFFICER 301350 0 3000 0 0 0 24108 0 28775 0 357233 0 0 0 JOSEPH S PONTOSKI VP. FINANCE AND BUSINESS ADMIN 300000 0 0 0 0 0 24000 0 26363 0 350363 0 0 0 MARY BALLINGER VP, MEETINGS AND EXHIBITS 267750 0 3000 0 0 0 21420 0 28775 0 320945 0 0 0 PART I, LINE 1A: SCHEDULE J, PART I, LINE 1A: FIRST-CLASS OR CHARTER TRAVEL IT IS THE POLICY OF THE ASSOCIATION TO AUTHORIZE FIRST CLASS TRAVEL ARRANGEMENTS FOR THE CHIEF EXECUTIVE OFFICER IN ORDER TO ACCOMMODATE BUSINESS TRAVEL SCHEDULES AND FACILITATE ONGOING BUSINESS TRANSACTIONS. PART II, BONUS AND INCENTIVE COMPENSATION: IN 2024, THE ACCR CEO RECEIVED A ONE-TIME PAYMENT OF $450,000 ASSOCIATED WITH THE DEFERRAL OF MERIT INCREASES FOR THE PAST FIVE YEARS - 2019-2023. PART II, OTHER REPORTABLE COMPENSATION: THE EMPLOYMENT CONTRACT FOR THE AACR CEO CALLS FOR ANNUAL CONTRIBUTIONS TO A DEFERRED COMPENSATION PLAN. DUE TO STATUTORY AND REGULATORY REQUIREMENTS, A PORTION OF THESE ANNUAL PAYMENTS CAN NO LONGER BE DEFERRED INTO A QUALIFIED PLAN AND MUST BE PAID OUT ANNUALLY AND CLASSIFIED AS OTHER REPORTABLE COMPENSATION. IN ADDITION, THE COMPANY PROVIDES AN ANNUAL CAR ALLOWANCE THAT IS ALSO INCLUDED AS PART OF OTHER COMPENSATION. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION HAS ONE CLASS OF VOTING MEMBER. EACH VOTING MEMBER IS ELIGIBLE TO VOTE OR TO HOLD THE OFFICE AND HAS THE SAME VOTING RIGHT - ONE VOTE PER MEMBER. FORM 990, PART VI, SECTION A, LINE 7A ELECTION OF MEMBERS OF THE GOVERNING BODY SHALL BE BY BALLOT DISTRIBUTED TO VOTING MEMBERS OF THE ORGANIZATION. THE CANDIDATE RECEIVING THE HIGHEST NUMBER OF VOTES CAST SHALL BE ELECTED. FORM 990, PART VI, SECTION A, LINE 7B GOVERNING BODY DECISIONS SUBJECT TO APPROVAL BY MEMBERS DECISIONS OF THE BOARD TO AMEND THE BY-LAWS OR TO AUTHORIZE THE ESTABLISHMENT OF A LOCAL SECTION REQUIRE APPROVAL BY MEMBERSHIP OF THE ASSOCIATION. FORM 990, PART VI, SECTION B, LINE 11B PRIOR TO ITS FILING WITH THE IRS, A COPY OF THE FINAL FORM 990 IS PROVIDED TO EACH VOTING MEMBER OF THE GOVERNING BODY AND TO THE FINANCE AND AUDIT COMMITTEE ON AN ANNUAL BASIS AS PART OF THEIR FIDUCIARY RESPONSIBILITY TO UNDERSTAND AND REVIEW THE ORGANIZATION'S FINANCES. FORM 990, PART VI, SECTION B, LINE 12C EACH VOTING MEMBER OF THE GOVERNING BODY IS REQUIRED TO ANNUALLY ACKNOWLEDGE ANY CONFLICTS BY SIGNING THE CORPORATE CONFLICT OF INTEREST STATEMENT AND DETAILING ALL POTENTIAL CONFLICTS. FORM 990, PART VI, SECTION B, LINE 15 INDEPENDENT DATA DETAILING COMPARABLE COMPENSATION IS PURCHASED ANNUALLY AND PROVIDED TO A COMPENSATION COMMITTEE WHICH EVALUATES SALARY LEVELS IN COMPARISON TO PEER GROUPS. FORM 990, PART VI, SECTION C, LINE 19 THE FINANCIAL STATEMENTS AND FORM 990 ARE POSTED ON THE ORGANIZATION'S WEBSITE (WWW.AACR.ORG). THEY WILL BE PROVIDED ON REQUEST AND ARE ALSO AVAILABLE FOR INSPECTION AT THE ORGANIZATION'S OFFICE. FORM 990, PART VII, SECTION A, COMPENSATION FROM RELATED ORG FOR THE CEO AND CFO, THE ALLOCATION IS BASED UPON AN ESTIMATE OF THE AMOUNT OF THEIR TIME SPENT IN THIS AREA - 10% FOR THE CEO, 5% FOR THE CFO. FORM 990, PART XI, LINE 9, CHANGE IN NET ASSETS CHANGE IN INTEREST IN NET ASSETS OF AFFILIATE-WITHOUT DONOR RESTRICTIONS $(1,669,599) CHANGE IN INTEREST IN NET ASSETS OF AFFILIATE-WITH DONOR RESTRICTIONS $251,012 NET CHANGE IN FUND BALANCE - $(1,403,587). AMERICAN ASSOCIATION FOR CANCER RESEARCH 615 CHESTNUT STREET 17TH FLOOR PHILADELPHIA PA 19106 233100004 SEE SCH O PA 501(C)(3) LINE 12A, I AACR true AMERICAN ASSOCIATION FOR CANCER RESEARCH C/O TMF CANADA MANAGEMENT INC 330 TORONTO ONTARIO CA SEE SCH O CA 501(C)(3) LINE 10 AACR true false false true false false false false false false false false false true true true false false true false AMERICAN ASSOCIATION FOR CANCER RESEARCH FDN C 47916782 ACCRUAL METHOD AMERICAN ASSOCIATION FOR CANCER RESEARCH FDN R 1204000 ACCRUAL METHOD PART II, IDENTIFICATION OF RELATED TAX-EXEMPT ORGANIZATIONS NAME OF RELATED ORGANIZATION: AMERICAN ASSOCIATION FOR CANCER RESEARCH FOUNDATION DIRECT CONTROLLING ENTITY: AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC. NAME AND ADDRESS OF RELATED ORGANIZATION: AMERICAN ASSOCIATION FOR CANCER RESEARCH INTERNATIONAL - CANADA C/O TMF CANADA MANAGEMENT INC., 330 BAY STREET, SUITE 820 TORONTO, ONTARIO, CANADA DIRECT CONTROLLING ENTITY: AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC. PART II, COLUMN B: PRIMARY ACTIVITY THE PURPOSE OF THE AACR FOUNDATION IS TO RAISE FUNDS AND SOLICIT GRANTS AND CONTRIBUTIONS TO BENEFIT, SUPPORT AND PROMOTE ITS PARENT ORGANIZATION - AACR'S MISSION IS DESCRIBED ON PAGE 2, PART III. THE PURPOSE OF AACR INTERNATIONAL - CANADA IS TO PROMOTE HEALTH BY SUPPORTING, MANAGING AND CONDUCTING NEW AND INNOVATIVE RESEARCH FOR THE CURE, PREVENTION AND TREATMENT OF CANCER, AND BY FOSTERING COLLABORATION AMONGST SCIENTISTS ENGAGED IN CANCER RESEARCH. IT INTENDS TO ADVANCE EDUCATION BY DEVELOPING AND OPERATING PROGRAMS, CONFERENCES, SEMINARS AND WORKSHOPS DESIGNED TO TRAIN STUDENTS AND SCIENTISTS AND ADVANCE THEIR UNDERSTANDING OF CANCER ETIOLOGY, PREVENTION, DIAGNOSIS AND TREATMENT.